What Are The Primary Biological Routes Of Skin Penetration, And How Do Molecular Properties Influence Device-Assisted Transdermal Delivery? Discover Key Insights For Optimized Treatment Outcomes.

The three primary routes of skin penetration are transcellular, intercellular, and transfollicular. Molecular size, lipophilicity, polarity, charge, and solubility determine which route is most favorable, but the stratum corneum strongly limits passive delivery. Device-assisted methods such as microneedling, ultrasound, and iontophoresis improve delivery by creating pathways or applying energy that reduces these barriers.

Molecular properties determine whether an active can cross the stratum corneum passively; device assistance changes the barrier rather than eliminating the need for suitable formulation and molecule–tissue compatibility.

How the Skin Controls Molecular Transport

The stratum corneum is the principal barrier

The stratum corneum consists of flattened, keratin-filled cells embedded in organized lipid layers. It behaves like a “brick-and-mortar” barrier: the cells provide structural resistance, while the surrounding lipids regulate molecular diffusion.

This barrier particularly restricts molecules that are large, highly polar, poorly soluble in skin lipids, or strongly charged.

Passive penetration depends on partitioning and diffusion

A molecule must first leave its formulation, partition into the stratum corneum, diffuse through it, and then enter the viable skin layers. Effective delivery therefore depends on both chemical affinity for the skin barrier and mobility through that barrier.

A molecule that is too hydrophilic may not enter the lipid-rich stratum corneum efficiently. One that is extremely lipophilic may enter the barrier but partition poorly into the more aqueous tissue beneath it.

The Three Primary Biological Routes

Transcellular penetration

The transcellular route passes directly through corneocytes and the lipid structures within or surrounding them. Molecules using this pathway encounter repeated changes between protein-rich cellular material and lipid-rich regions.

This route generally favors small molecules with a suitable balance of lipophilicity and hydrophilicity. It is not accurate to treat transcellular transport as exclusively hydrophilic or exclusively lipophilic, because the molecule must negotiate both aqueous and lipid environments.

Intercellular penetration

The intercellular route travels between corneocytes through the continuous lipid domains of the stratum corneum. These narrow pathways are often the dominant route for many small molecules because they provide a connected diffusion network.

Small, moderately lipophilic molecules are generally better suited to this pathway. Highly polar or strongly ionized molecules tend to move through these lipid regions poorly unless the barrier is modified.

Transfollicular penetration

The transfollicular route passes through hair follicles and associated sebaceous gland structures. It can provide access to deeper skin structures and may be particularly relevant for molecules that interact with follicular or glandular targets.

Follicular pathways can accommodate some molecules that penetrate the intact stratum corneum poorly, but they are not a universal route for large or polar compounds. Their usefulness depends on follicle density, follicle size, formulation behavior, and the target location.

How Molecular Properties Determine Delivery

Molecular size

Smaller molecules generally diffuse through intact skin more readily than larger molecules. As molecular size increases, diffusion slows and the probability of crossing the tightly organized stratum corneum decreases.

Device-assisted systems are therefore especially valuable when the active is too large for efficient passive transport.

Lipophilicity and hydrophilicity

The active must have enough lipophilicity to enter the stratum corneum but enough hydrophilicity to move into viable tissue and, where relevant, systemic circulation.

This balance is often more important than maximizing either property alone. Excessive lipophilicity can cause retention in the stratum corneum, while excessive hydrophilicity can prevent initial entry.

Charge and ionization

Charged molecules generally cross the lipid-rich stratum corneum less efficiently than their neutral forms. However, charge can be advantageous for iontophoresis, because an applied electrical field can help drive ions through or around the skin barrier.

The degree of ionization is influenced by molecular pKa and formulation pH. Consequently, pH can affect both passive penetration and device-assisted transport.

Solubility and formulation compatibility

The molecule must be sufficiently soluble in its vehicle to provide a usable concentration gradient at the skin surface. It must also be able to partition from the formulation into the skin.

A formulation that holds the active too tightly may reduce delivery, while one that is unstable or poorly tolerated can compromise performance and safety.

Concentration and dose

Passive transport is influenced by the concentration gradient between the formulation and the skin. Increasing concentration can improve delivery only within practical limits, because solubility, irritation, crystallization, and tissue tolerance may become limiting factors.

A device can increase transport efficiency, but it does not remove the need to control the delivered dose.

How Devices Change the Delivery Problem

Microneedling and microneedle systems

Microneedles create temporary microscopic pathways through the stratum corneum. This reduces dependence on passive diffusion through intact barrier lipids and can improve delivery of molecules that are otherwise too large or too hydrophilic.

The resulting transport depends on needle geometry, insertion depth, channel lifetime, formulation properties, and the active’s stability. Microneedling can also produce local tissue effects that must be considered separately from delivery efficiency.

Ultrasound-assisted delivery

Ultrasound, or sonophoresis, uses acoustic energy to increase skin permeability and promote movement of the active into tissue. It can disturb barrier organization and improve transport for selected formulations.

Its performance depends on operating conditions, treatment duration, coupling medium, formulation, and molecular characteristics. Ultrasound is therefore a controlled process variable, not a substitute for appropriate molecule design.

Iontophoresis

Iontophoresis applies a low electrical current to assist transport, particularly for ionized or charged molecules. The electric field can repel charged species from an electrode and promote movement through the skin, while electroosmotic flow may also contribute to transport.

It is less suitable for molecules that are neutral and poorly soluble unless the formulation and system use another mechanism to improve their movement.

Matching Molecular Properties to the Delivery Route

When passive delivery is the goal

Passive delivery is most realistic for relatively small molecules with adequate solubility and a balanced affinity for lipid and aqueous environments. The formulation should maintain the active in a stable, available form at the skin surface.

The three biological routes may operate simultaneously, but the relative contribution of each depends on the molecule, formulation, skin site, and condition of the barrier.

When the active is large or strongly polar

Large, highly polar, or strongly charged molecules usually face substantial resistance from intact stratum corneum. In these cases, microneedles or other barrier-disrupting approaches may be more suitable than relying on passive intercellular or transcellular diffusion.

The objective is to create a controlled route around the limiting barrier while preserving acceptable tolerability and delivery precision.

When the active is charged

Iontophoresis may be appropriate when the active has a controllable ionic form and the formulation can maintain adequate solubility and stability. Its design must account for polarity, current density, skin condition, and the risk of irritation.

A charged molecule is not automatically a good iontophoretic candidate; its behavior in the complete formulation and device system must be evaluated.

Understanding the Trade-offs

Greater penetration can increase irritation risk

Increasing skin permeability may improve delivery, but it can also increase exposure of viable tissue to the active, excipients, or device-generated stress. Barrier disruption may produce erythema, inflammation, discomfort, or increased sensitivity.

The desired outcome is controlled delivery, not maximum penetration under all conditions.

Follicular delivery is useful but variable

Hair follicles can act as localized pathways and reservoirs, but their distribution varies by body site and individual. Results from one anatomical area may not translate directly to another.

Follicular transport should therefore be evaluated against the intended target rather than assumed to provide uniform whole-skin delivery.

Devices add process complexity

Device-assisted delivery introduces additional variables, including energy or insertion parameters, treatment timing, contact conditions, sterility, formulation compatibility, and user technique.

These variables can produce greater performance variability than a simple topical application if the system is not carefully controlled.

More permeable does not always mean more effective

An active may enter the skin efficiently but fail to reach the intended tissue, remain trapped in the barrier, degrade, or produce insufficient biological activity. Delivery should be assessed by target-site exposure and therapeutic or cosmetic effect, not penetration depth alone.

How to Apply This to Your Project

The most reliable approach is to characterize the active first, then select the biological route and device that address its dominant barrier.

If your primary focus is passive topical delivery: Prioritize a relatively small molecule with balanced lipophilicity, adequate solubility, and a formulation that supports partitioning into and beyond the stratum corneum.
If your primary focus is delivery of a large or highly polar active: Consider microneedle-based or other barrier-modifying approaches that create controlled pathways through the principal barrier.
If your primary focus is a charged active: Evaluate iontophoresis while accounting for ionization, formulation pH, solubility, electrode arrangement, and skin tolerability.
If your primary focus is follicular targeting: Assess transfollicular delivery according to the target site, follicle characteristics, formulation behavior, and desired depth rather than relying on generalized penetration assumptions.
If your primary focus is safety and reproducibility: Optimize for controlled target-site exposure and consistent treatment conditions, not simply the highest measured skin penetration.

Understanding the relationship between route, molecular properties, and device behavior allows transdermal systems to be designed around the actual barrier rather than tested by trial and error.

Summary Table:

Route	Pathway	Preferred Molecules	Device Relevance
Transcellular	Through corneocytes and lipids	Small, balanced lipophilicity/hydrophilicity	Microneedling can create pathways for larger molecules
Intercellular	Between corneocytes via lipid matrix	Small, moderately lipophilic	Ultrasound disrupts lipids to enhance delivery
Transfollicular	Via hair follicles and sebaceous glands	Molecules targeting follicular structures	Microneedling or iontophoresis can enhance follicular delivery

Elevate your aesthetic practice with BELIS's advanced transdermal delivery systems, designed to optimize efficacy for your specific applications. Our portfolio includes microneedling, HIFU, and RF devices tailored for clinics and premium salons. Contact us today to discover how our technology can enhance your treatment outcomes and patient satisfaction.